Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/K ATP channel pathway and PPARγ receptors.

MLA

Alizamani, Ehsan, et al. “Montelukast, a Cysteinyl Leukotriene Receptor Antagonist, Exerts Local Antinociception in Animal Model of Pain through the L-Arginine/Nitric Oxide/Cyclic GMP/K ATP Channel Pathway and PPARγ Receptors.” The International Journal of Neuroscience, vol. 131, no. 10, Oct. 2021, pp. 1004–11. EBSCOhost, https://doi.org/10.1080/00207454.2020.1769618.

APA

Alizamani, E., Ghorbanzadeh, B., Naserzadeh, R., & Mansouri, M. T. (2021). Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/K ATP channel pathway and PPARγ receptors. The International Journal of Neuroscience, 131(10), 1004–1011. https://doi.org/10.1080/00207454.2020.1769618

Chicago

Alizamani, Ehsan, Behnam Ghorbanzadeh, Reza Naserzadeh, and Mohammad Taghi Mansouri. 2021. “Montelukast, a Cysteinyl Leukotriene Receptor Antagonist, Exerts Local Antinociception in Animal Model of Pain through the L-Arginine/Nitric Oxide/Cyclic GMP/K ATP Channel Pathway and PPARγ Receptors.” The International Journal of Neuroscience 131 (10): 1004–11. doi:10.1080/00207454.2020.1769618.